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Summary: We describe a case of the heterozygous antitrypsin phenotype IS. The 20 years old female employee
had been recurrently suffering from cutaneous vasculitis over a period of three years. Serum trypsin Inhibitor was
found to be high (1394 ImU) during the acute stage of the disease. No other serological or physical abnormalities
were detected. A relationship between certain Pi (the term Pi indicating protease Inhibitor = OL\ -antitrypsin) alleles
and vasculitis is possible but not certain, äs three out of four other patients with this disease were MM phenotypes,
the other one being MS type.
%
Fall eines seltenen heterozygoten o^ -Antitrypsin-Phänotyps: IS
Zusammenfassung: Wir beschreiben einen Fall des heterozygoten Phänotyps des c^ -Antitrypsins IS. Die 20 Jahre
alte Patientin erkrankte in den letzten drei Jahren in unregelmäßigen Abständen an einer cutanen Vasculitis. Die
Serumhemmkapazität gegen Trypsin war während der akuten Phase der Krankheit hoch (1394 ImU). Es wurden
keine anderen serologischen oder physischen Abnormitäten beobachtet. Eine Beziehung zwischen besonderen
Pi(= Proteaseinhibitor = «j-Antitrypsin^Allelen und Vasculitis ist möglich, aber nicht sicher, da von vier anderen
Patienten mit dieser Krankheit drei zu den MM-Phänotypen und einer zu den MS-Typen gehörten.
Introduction
It is well known that individuals homozygous with
respect to the at-antitrypsin allele Z have an increased
risk of panacinar emphysema, chronic obstructive
pulmonary disease, liver cirrhosis and malignant hepä-
toma(l-S).
Reports concerning the pathological role of the hetero-
zygous QLi ̂ antitrypsin MZ and MS väriänts are contro-
versial; some studies suggest a relationship to pulmonary
diseases, others do not (6—11). There is evideiice that
heterozygosity may becoine a deciding pathological
factor in the presence of .additional pulmonary risks like
smoking, exposure to industrial dusts, fumes and/or
individual predisposition, e.g. abnormal enzyme patterns
(10,11).
From the genetic point of view it is possible for 25%
of children from heterozygous parents to have the homo-
zygous SS or ZZ type, whereas the other 50% will be in
danger having heterozygous väriänts (9).
As opposed to the MZ and MS types, which have been
the subject of several studies, certain rare väriänts can be
described only in the form of case reports.
Case History and Results of Laboratory Investigations
For the last three years the 20 year old femaie employee has
suffered recurrently from raised, erythematous cutaneous lesions,
which developed simultaneously on average once to four times
every 6 weeks. These eruptions vvere predominantly localized
symmetrically on the lower extremities and were accompanied
by marked swelling of feet, malleolar regions and lower legs.
They also disappeared spontaneously within a week without
treatment, or even within few days if corticosteroids were
administered. Skin biopsy specimens showed mixed cellular
Infiltrate of blood vessels (neutrophils, lymphocytes and mono-
cytes), nuclear debris and erythrocyte extravasation. In direct
immunoflourescence studies there was strong evidence for
deposition of immune complexes in vascular lesions (deposition
of C 3, IgM and fibrin in the walls of superficial dermal venules).
Immune complexes, antinuclear antibodies, or rheumatoid factors
were not detectable in the serum; C 3 , C 4 , C 5 , C 1 Inhibitor,
bilirubin, prothrombin, aspartate aminotransferase, alanine
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aminotransfcrasc» -glutamyltransfcrase, alkaline phosphatase
and cholinesterase, and erythrocyte Sedimentation rate were
within normal ranges.
Extensive cünical and laboratory investigations including
pulmonary function tests suggested no further organic abnorm-
alities, except chronic tonsillitis. The etiology of the disease
remained unknown; intracutancous and epidermal skin tests
with a battery of allergens were negative. Interruption of oral
contraceptives, the only drugs the patient took, led to no changes
in the Symptoms described.
showed that the parents of the patient have Mjl and
MI S phenotypes (flg. 2). Serum trypsin inhibitory
capacity was normal in the mother's serum (l 145 ImU;
normal ränge for IM-types 1150 ± 180 ImU), decreased
in the father's serum (783 ImU; normal ranges for MS-
types: 1060 ± 180 ImU), but rather high in the serum
of the above mentioned patient (1394 ImU).
Methods
The a-j-antitrypsin phenotypes were determined by isoelectric
focusing on polyacrylamide gel slabs. As previously described
(12), 20 of each serum was added to specially prepared gel
slabs of l mm thickness.
Serum trypsin inhibitory capacity
Quantitative functional analyses of serum cq-antitrypsin were
performed according to the method of Fritz et al. (13). One
inhibitor milliunit (ImU) is defined äs reduction of the trypsin-
catalyzed hydrolysis of the Substrate N-a-benzyl-£-arginine-
p-nitroanilide by l per min (*A = 0.00332 in 3 ml solvent).
Results
Using M tM2 standardized sera and reference sera of
subjects with MI S and M! I phenotypes the rare pheno-
type IS was identified (flg. 1). Additional support for
these results was obtained by a family study, which
Discussion
Many studies on the distribtition of %-antitrypsin
phenotypes in different populations have beeil published.
Based upon the mean gene frequency frorri the studies
mentioned in table l we ealculated a frequency of the
heterozygous variant IS of 8.6 in 100 000.















































































































































Fig. 1. Phenotyping of <*rantitrypsin variants IS, MS and MI on
polyacrylamide gel.
It remains tö be proven if there is a relationship betweeri
IS type and other Pi types on the one hand and the
occurrence of immune complex väculitis on the other
hand. In order to clarify this qüestion, screening studies
of patients with this disease seem to be necessary. Otir
preliminary studies showed that three out pf four
patients with strong evidence for irriTfturie complex
vasculitis (identification of deposits of imrnunoglobulins
and C 3 within and around venules of dermal lesions)
were of the MM type and the föüfth one of this group
belonged to the MjS type. Furthermore, three out of
the latter group also had significantly elevated serum
trypsin inhibitory capacities (> 1499 ImU).
It is well known that c^ -äntitrypsin behaves äs an acute
phase reactant and that it's serum concentration increases
during inflarnmation. This may be the cause of the
Fig. 2. Family pedigree of propositus protein inhibitor IS: pheno- elevated serum trypsin inhibitory capacity values in
types and serum trypsin inhibitory capacities. patients with acute Steges of vascuKtis.
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